Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Tapan M. Kadia

Clofarabine, Idarubicin, and Cytarabine (CIA) as Frontline Therapy for Patients <= 60 Years With Newly Diagnosed Acute Myeloid Leukemia (AML)

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Final Results of a Phase 2, Open-Label Study of Indisulam, Idarubicin, and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

Cancer
Cancer ResearchOncology
2018English

NPM1 Mutant Variant Allele Frequency Correlates With Leukemia Burden but Does Not Provide Prognostic Information in NPM1-mutated AML

American Journal of Hematology
Hematology
2019English

Prognosis of Patients With Intermediate Risk IPSS-R Myelodysplastic Syndrome Indicates Variable Outcomes and Need for Models Beyond IPSS-R

American Journal of Hematology
Hematology
2018English

Failure of Hypomethylating Agent–Based Therapy in Myelodysplastic Syndromes

Seminars in Oncology
OncologyHematology
2011English

Progress in Acute Myeloid Leukemia

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy